Antoine Marfan and his syndrome

one hundred years later.

Research output: Contribution to journalArticle

Abstract

In 1896, in the Bulletin of the Medical Society of Paris, Antoine Marfan described a five-year-old girl with arachnodactyly. It took almost 50 years to fully elucidate this syndrome including aneurysm of the ascending aorta. It is critical to make an early diagnosis of Marfan aneurysm because there is a high frequency of dissection and rupture once the aortic diameter reaches 6 cm. Before the availability of the Bentall composite graft procedure in 1968, the operative results were very poor. The Bentall operation now carries a 30-day mortality rate of less than 5% at major cardiac surgical centers. Two hundred and thirty-one Marfan patients underwent aortic root replacement at The Johns Hopkins Hospital between September 1976 and December 1997. The 30-day mortality for 198 patients undergoing elective aortic root replacement was 0%. Two of 33 patients undergoing urgent surgery died in the first 30 days after surgery; both of these patients arrived in the operating room with ruptured aortas. The actuarial survival for the 231 patients undergoing aortic root replacement was 88% at five years, 81% at ten years, and 75% at 20 years. Clearly, the outlook for Marfan patients undergoing elective aortic root replacement has been excellent. Accompanying the steadily improving surgical results have been spectacular developments in understanding the genetic role in Marfan families. Since 1991, over 150 mutations have been discovered in the gene that is critical in the production of the structural protein fibrillin. The identification of mutations in the fibrillin gene has enabled the diagnosis of Marfan disease in some patients before they become symptomatic; prenatal diagnosis has been achieved in some patients. The ultimate hope for Marfan families is to eliminate the disease by genetic manipulation; however, this may be years away.

Original languageEnglish (US)
Pages (from-to)247-252
Number of pages6
JournalMaryland medical journal (Baltimore, Md. : 1985)
Volume47
Issue number5
StatePublished - 1998

Fingerprint

Marfan Syndrome
Aneurysm
Aorta
Hope
Arachnodactyly
Aortic Rupture
Mutation
Inborn Genetic Diseases
Mortality
Medical Societies
Paris
Operating Rooms
Prenatal Diagnosis
Ambulatory Surgical Procedures
Genes
Dissection
Early Diagnosis
Transplants
Survival

Cite this

Antoine Marfan and his syndrome : one hundred years later. / Gott, Vincent L.

In: Maryland medical journal (Baltimore, Md. : 1985), Vol. 47, No. 5, 1998, p. 247-252.

Research output: Contribution to journalArticle

@article{942bdbc1dd514c57b5cd6ae97b17661a,
title = "Antoine Marfan and his syndrome: one hundred years later.",
abstract = "In 1896, in the Bulletin of the Medical Society of Paris, Antoine Marfan described a five-year-old girl with arachnodactyly. It took almost 50 years to fully elucidate this syndrome including aneurysm of the ascending aorta. It is critical to make an early diagnosis of Marfan aneurysm because there is a high frequency of dissection and rupture once the aortic diameter reaches 6 cm. Before the availability of the Bentall composite graft procedure in 1968, the operative results were very poor. The Bentall operation now carries a 30-day mortality rate of less than 5{\%} at major cardiac surgical centers. Two hundred and thirty-one Marfan patients underwent aortic root replacement at The Johns Hopkins Hospital between September 1976 and December 1997. The 30-day mortality for 198 patients undergoing elective aortic root replacement was 0{\%}. Two of 33 patients undergoing urgent surgery died in the first 30 days after surgery; both of these patients arrived in the operating room with ruptured aortas. The actuarial survival for the 231 patients undergoing aortic root replacement was 88{\%} at five years, 81{\%} at ten years, and 75{\%} at 20 years. Clearly, the outlook for Marfan patients undergoing elective aortic root replacement has been excellent. Accompanying the steadily improving surgical results have been spectacular developments in understanding the genetic role in Marfan families. Since 1991, over 150 mutations have been discovered in the gene that is critical in the production of the structural protein fibrillin. The identification of mutations in the fibrillin gene has enabled the diagnosis of Marfan disease in some patients before they become symptomatic; prenatal diagnosis has been achieved in some patients. The ultimate hope for Marfan families is to eliminate the disease by genetic manipulation; however, this may be years away.",
author = "Gott, {Vincent L}",
year = "1998",
language = "English (US)",
volume = "47",
pages = "247--252",
journal = "Maryland Medical Journal",
issn = "1538-2656",
publisher = "Medical and Chirugical Faculty of Maryland",
number = "5",

}

TY - JOUR

T1 - Antoine Marfan and his syndrome

T2 - one hundred years later.

AU - Gott, Vincent L

PY - 1998

Y1 - 1998

N2 - In 1896, in the Bulletin of the Medical Society of Paris, Antoine Marfan described a five-year-old girl with arachnodactyly. It took almost 50 years to fully elucidate this syndrome including aneurysm of the ascending aorta. It is critical to make an early diagnosis of Marfan aneurysm because there is a high frequency of dissection and rupture once the aortic diameter reaches 6 cm. Before the availability of the Bentall composite graft procedure in 1968, the operative results were very poor. The Bentall operation now carries a 30-day mortality rate of less than 5% at major cardiac surgical centers. Two hundred and thirty-one Marfan patients underwent aortic root replacement at The Johns Hopkins Hospital between September 1976 and December 1997. The 30-day mortality for 198 patients undergoing elective aortic root replacement was 0%. Two of 33 patients undergoing urgent surgery died in the first 30 days after surgery; both of these patients arrived in the operating room with ruptured aortas. The actuarial survival for the 231 patients undergoing aortic root replacement was 88% at five years, 81% at ten years, and 75% at 20 years. Clearly, the outlook for Marfan patients undergoing elective aortic root replacement has been excellent. Accompanying the steadily improving surgical results have been spectacular developments in understanding the genetic role in Marfan families. Since 1991, over 150 mutations have been discovered in the gene that is critical in the production of the structural protein fibrillin. The identification of mutations in the fibrillin gene has enabled the diagnosis of Marfan disease in some patients before they become symptomatic; prenatal diagnosis has been achieved in some patients. The ultimate hope for Marfan families is to eliminate the disease by genetic manipulation; however, this may be years away.

AB - In 1896, in the Bulletin of the Medical Society of Paris, Antoine Marfan described a five-year-old girl with arachnodactyly. It took almost 50 years to fully elucidate this syndrome including aneurysm of the ascending aorta. It is critical to make an early diagnosis of Marfan aneurysm because there is a high frequency of dissection and rupture once the aortic diameter reaches 6 cm. Before the availability of the Bentall composite graft procedure in 1968, the operative results were very poor. The Bentall operation now carries a 30-day mortality rate of less than 5% at major cardiac surgical centers. Two hundred and thirty-one Marfan patients underwent aortic root replacement at The Johns Hopkins Hospital between September 1976 and December 1997. The 30-day mortality for 198 patients undergoing elective aortic root replacement was 0%. Two of 33 patients undergoing urgent surgery died in the first 30 days after surgery; both of these patients arrived in the operating room with ruptured aortas. The actuarial survival for the 231 patients undergoing aortic root replacement was 88% at five years, 81% at ten years, and 75% at 20 years. Clearly, the outlook for Marfan patients undergoing elective aortic root replacement has been excellent. Accompanying the steadily improving surgical results have been spectacular developments in understanding the genetic role in Marfan families. Since 1991, over 150 mutations have been discovered in the gene that is critical in the production of the structural protein fibrillin. The identification of mutations in the fibrillin gene has enabled the diagnosis of Marfan disease in some patients before they become symptomatic; prenatal diagnosis has been achieved in some patients. The ultimate hope for Marfan families is to eliminate the disease by genetic manipulation; however, this may be years away.

UR - http://www.scopus.com/inward/record.url?scp=0032209670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032209670&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 247

EP - 252

JO - Maryland Medical Journal

JF - Maryland Medical Journal

SN - 1538-2656

IS - 5

ER -